Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Prediction of treatment response and recurrence with texture analysis or volumetric parameters on FDG PET in patients with esophageal cancer receiving neoadjuvant chemotherapy and surgery

Mitsuaki Tatsumi, Kayako Isohashi, Hiroki Kato, Tadashi Watabe and Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1596;
Mitsuaki Tatsumi
4Osaka University Graduate School of Medicine Suita/ Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayako Isohashi
2Suita City Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Kato
1Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
5Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
3Osaka University Graduate School of Medicine Suita, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1596

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Mitsuaki Tatsumi4,
  2. Kayako Isohashi2,
  3. Hiroki Kato1,
  4. Tadashi Watabe5 and
  5. Jun Hatazawa3
  1. 1Osaka Japan
  2. 2Suita City Japan
  3. 3Osaka University Graduate School of Medicine Suita, Osaka Japan
  4. 4Osaka University Graduate School of Medicine Suita/ Osaka Japan
  5. 5Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 20161000
Jun 20162900
Jul 20161000
Aug 2016300
Sep 20161300
Oct 20161000
Nov 2016500
Dec 20162200
Jan 2017300
Feb 20171100
Mar 20171600
Apr 2017800
May 2017300
Jun 2017700
Jul 20171300
Aug 20172900
Sep 2017600
Oct 2017400
Nov 20173800
Dec 2017700
Jan 2018500
Feb 2018100
Mar 20181100
Apr 2018400
May 20181100
Aug 2018800
Sep 2018200
Nov 20182200
Dec 2018200
Apr 2019300
May 2019400
Jun 2019500
Jul 2019200
Oct 2019100
Nov 2019100
Feb 2020100
Mar 20201000
May 20201600
Jun 2020100
Aug 2020100
Sep 2020100
Oct 2020100
Nov 2020700
Dec 2020100
Jan 2021400
Feb 20211000
Mar 2021700
Apr 2021800
May 20211100
Jun 2021500
Jul 2021300
Aug 2021700
Sep 2021600
Oct 2021500
Nov 2021100
Dec 20211700
Jan 2022300
Feb 20221300
Mar 2022200
Apr 2022500
May 2022300
Jun 2022800
Aug 2022500
Sep 2022400
Oct 2022100
Nov 2022200
Dec 2022100
Jan 2023100
Mar 2023300
Apr 2023200
May 2023100
Jun 2023500
Jul 2023100
Aug 2023200
Sep 2023400
Oct 2023500
Nov 2023300
Dec 2023500
Jan 2024500
Feb 2024400
Mar 2024600
Apr 20242200
May 2024500
Jun 2024100
Jul 2024500
Aug 2024300
Sep 2024600
Oct 2024100
Nov 2024400
Dec 2024200
Jan 2025400
Feb 2025200
Mar 2025200
Apr 2025200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of treatment response and recurrence with texture analysis or volumetric parameters on FDG PET in patients with esophageal cancer receiving neoadjuvant chemotherapy and surgery
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prediction of treatment response and recurrence with texture analysis or volumetric parameters on FDG PET in patients with esophageal cancer receiving neoadjuvant chemotherapy and surgery
Mitsuaki Tatsumi, Kayako Isohashi, Hiroki Kato, Tadashi Watabe, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1596;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prediction of treatment response and recurrence with texture analysis or volumetric parameters on FDG PET in patients with esophageal cancer receiving neoadjuvant chemotherapy and surgery
Mitsuaki Tatsumi, Kayako Isohashi, Hiroki Kato, Tadashi Watabe, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1596;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • STANDARDIZATION OF TUMOR VOLUME DELINEATION BY PET-CT AND CT IN PATIENTS OF HEAD AND NECK CANCER-A PRELIMINARY ANALYSIS
  • HIGH FDG UPTAKE ON PRE-RADIOTHERAPY PET/CT AND PREFERENTIAL SITES OF LOCAL RELAPSE AFTER CHEMORADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER
Show more Oncology, Clinical Science Track

MTA I: GI Non-Colorectal/Colorectal Posters

  • Tc-99m MAA Hepatic Perfusion Imaging to Predict the Response of Treatment for Patients with Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.
  • 18F-FDG PET-based response prediction in rectal cancer: comparison of different blood glucose level normalization methods.
  • The relationship and optimal cutoff value between dual-phase corrected whole-body uptake ratio (CUR) and serum CEA level in recurrent/metastatic colorectal carcinoma: Dual-phase whole body protocol using time-of-flight (TOF) imaging
Show more MTA I: GI Non-Colorectal/Colorectal Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire